Abbott Spins Off its Hospital Products Group--and Then There Were None
Executive Summary
Abbott's announced spin-off of its hospital supply business suggests once and for all that a key medical device model of the 1980s is now dead. At the same time, it creates an enormous company with significant resources.
You may also be interested in...
GE Grabs the Spotlight in IVD
The entry by GE into the core lab business via its acquisition of Abbott's clinical diagnostics businesses follows a similar move by Siemens last year, and suggests IVD may be best suited for generalist industrial giants. While the pricing pressures that have dogged this segment of diagnostics are not likely to abate, existing players--including Abbott--are continuing to develop high-margin molecular diagnostic tests that they expect the new players will want to incorporate into their platforms.
GE Grabs the Spotlight in IVD
The entry by GE into the core lab business via its acquisition of Abbott's clinical diagnostics businesses follows a similar move by Siemens last year, and suggests IVD may be best suited for generalist industrial giants. While the pricing pressures that have dogged this segment of diagnostics are not likely to abate, existing players--including Abbott--are continuing to develop high-margin molecular diagnostic tests that they expect the new players will want to incorporate into their platforms.
Spinal Concepts: Leading Abbott into the Spine Market
The success of Abbott Laboratories' acquisition of Spinal Concepts may depend as much on company restraint as on company resources.